Sierra Leone, Liberia and Guinea must stand together to free their youth of this deadly synthetic cannabis. By Feyi Ogunade Kush is spreading...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - NEWS.MEDICAL.NET - A la Une - 30/Jul 04:39
Evidence lacking for widespread youth psychotropic prescribing
There's limited evidence to back up the widespread and increasing rates of prescribing mood-altering drugs (psychotropics) as the mainstay of mental health treatment for children and young people, warn experts in an editorial, published in the August issue of Drug and Therapeutics Bulletin (dtb)
Articles similaires
Kush Takes Hold Of West Africa’s Mano River Basin Youth – Analysis
eurasiareview.com - 10/Sep 23:17
Sierra Leone, Liberia and Guinea must stand together to free their youth of this deadly synthetic cannabis. By Feyi Ogunade Kush is spreading...
Rising Suicide Rates Among Indian Youth
medindia.net - 12/Sep 21:05
Rising suicide rates among Indian youth highlight increasing mental health struggles, driven by academic pressure, social issues, and lack of...
Risky Medication Mixes for Young Psychiatric Patients
medindia.net - 09/Sep 03:52
Risky combinations of psychiatric drugs prescribed to young patients, highlighting potential safety concerns and the need for cautious prescribing...
Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma
mountaintoday.in - 12/Sep 08:52
Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma
mountaintoday.in - 12/Sep 08:52
Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
Ratings agencies warn of downgrade if Boeing strike prolonged
aljazeera.com - 13/Sep 18:53
Agencies warn an extended strike could impact operations and finances, increasing the risk of a downgrade.
Traditional Siddha Drugs Show Promise in Combating Anemia
medindia.net - 11:02
The use of Siddha drug treatment can help reduce medlinkanemia/medlink among adolescent girls as per a study that highlights the potential of...
Traditional Siddha Drugs Show Promise in Combating Anemia
medindia.net - 11:02
The use of Siddha drug treatment can help reduce medlinkanemia/medlink among adolescent girls as per a study that highlights the potential of...
Travere Therapeutics Announces Full FDA Approval of Filspari (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
drugs.com - 05/Sep 05:09
SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...
Les derniers communiqués
-
Aucun élément